Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 279 No 7475 p458
27 October 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Society attacks EEA prescriptions

Proposals to allow pharmacists to dispense prescriptions written by non-UK registered doctors from within the European Economic Area and Switzerland will put them at odds with their professional ethics and patients could be put at risk, says the Royal Pharmaceutical Society (PDF 50K).

Responding to Government plans that have been put forward because of pressure from the European Commission (PJ, 25 August, p199), the Society set out its concerns centred on the first principle of its Code of Ethics, which requires pharmacists (and pharmacy technicians) to ensure that patients have safe and timely access to medicines.

If the proposals as outlined in the consultation document are implemented, UK pharmacists will face a number of practical problems in meeting their legal and professionals requirements. … The pharmacist could be placed in a professionally compromising position of a patient requiring vital medicines and a regulatory minefield to navigate in order to verify authenticity,” the Society says.

The Society’s view is that UK pharmacists could face serious obstacles when trying to verify prescriptions. These include problems verifying the registration status of non-UK prescribers, difficulties reading prescriptions written in a foreign language and further spoken language difficulties if anything on a prescription needed clarification.

“If these difficulties are not overcome, patient safety could be placed at risk,” the Society says.

Further concern is expressed over the proposal to exempt foreign prescriptions from the normal UK requirements for information that a prescription must contain.

The Society says that such an exemption would mean that foreign prescriptions were subject to lower controls than domestic ones and that this could undermine patient safety and make it harder for pharmacists to identify forged prescriptions.

Back to Top


©The Pharmaceutical Journal